Market erases gains to end flat amid volatility; Maruti Suzuki rises 5%

After touching a lifetime intra-day peak of 53,057.11, the 30-share BSE Sensex settled 14.25 points, or 0.03 per cent higher, at 52,588.71, marking its third straight session of ga­ins

BSE, sensex, market, shares, stocks, trading, brokers, investment, investors, growth, results, Q, earnings
Maruti Suzuki, which was the biggest laggard in Monday's session, topped the Sensex gainers' chart on Tuesday, with a jump of 5.25 per cent
Press Trust of India Mumbai
2 min read Last Updated : Jun 22 2021 | 11:40 PM IST
Equity benchmark Sensex ended on a flat note after scaling the 53,000-mark on Tuesday as investors booked profits at higher levels. A depreciating trend in the rupee also weighed on sentiment, said traders.

After touching a lifetime intra-day peak of 53,057.11, the 30-share BSE Sensex settled 14.25 points, or 0.03 per cent higher, at 52,588.71, marking its third straight session of ga­ins. Similarly, the broader NSE Nifty rose 26.25 points, or 0.17 per cent, to close at 15,772.75. Maruti Suzuki, which was the biggest laggard in Monday's session, topped the Sensex gainers' chart on Tuesday, with a jump of 5.25 per cent. L&T, UltraTech Cement, Tata Consultancy Services, Titan, Tata Steel, and Bajaj Auto were the other winners, advancing up to 2.2 per cent. On the other hand, Asian Paints, Bajaj Finance, Nestlé India, Hindustan Unilever, IndusInd Bank, and Sun Pharmaceutical Industries were among the major laggards, dropping up to 1.91 per cent.

The markets opened strong on the back of global cues and pick-up in the pace of vaccination. Tuesday's trade saw hectic activity in stocks pertaining to the 'unlock' theme, said S Ranganathan, head of research at LKP Securit­ies. Nearing Mount 53K, however, the Sensex witnessed profit-taking across the board in afternoon trade, he observed. Vinod Nair, head of research at Geojit Financial Services, said, "During early hours, Indian markets traded strongly, following Monday's rebound in western markets, which focused on economic recovery, partially offsetting concerns over a possible change in US Federal Reserve policy in the future."

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirusstock market tradingstock marketMaruti SuzukiVaccination

Next Story